219 related articles for article (PubMed ID: 23860753)
1. Correlation between reflectivity of subretinal fluid in OCT images and concentration of intravitreal VEGF in eyes with diabetic macular edema.
Sonoda S; Sakamoto T; Shirasawa M; Yamashita T; Otsuka H; Terasaki H
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5367-74. PubMed ID: 23860753
[TBL] [Abstract][Full Text] [Related]
2. Concentration gradient of vascular endothelial growth factor in the vitreous of eyes with diabetic macular edema.
Shimada H; Akaza E; Yuzawa M; Kawashima M
Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2953-5. PubMed ID: 19060271
[TBL] [Abstract][Full Text] [Related]
3. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
4. Blood components and OCT reflectivity evaluated in animal model.
Sonoda S; Sakamoto T; Shirasawa M; Yamashita T; Uchino E; Terasaki H
Curr Eye Res; 2014 Dec; 39(12):1200-6. PubMed ID: 25310458
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
6. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
[TBL] [Abstract][Full Text] [Related]
8. Optical coherence tomographic pattern may predict visual outcome after intravitreal triamcinolone for diabetic macular edema.
Gibran SK; Khan K; Jungkim S; Cleary PE
Ophthalmology; 2007 May; 114(5):890-4. PubMed ID: 17467527
[TBL] [Abstract][Full Text] [Related]
9. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
[TBL] [Abstract][Full Text] [Related]
10. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
[TBL] [Abstract][Full Text] [Related]
11. Aqueous humor analyses of diabetic macular edema patients with subretinal fluid.
Kwon JW; Kim B; Jee D; Cho YK
Sci Rep; 2021 Oct; 11(1):20985. PubMed ID: 34697354
[TBL] [Abstract][Full Text] [Related]
12. Optical coherence tomographic evaluation of foveal hard exudates in patients with diabetic maculopathy accompanying macular detachment.
Ota M; Nishijima K; Sakamoto A; Murakami T; Takayama K; Horii T; Yoshimura N
Ophthalmology; 2010 Oct; 117(10):1996-2002. PubMed ID: 20723993
[TBL] [Abstract][Full Text] [Related]
13. Relationship between fluorescein pooling and optical coherence tomographic reflectivity of cystoid spaces in diabetic macular edema.
Horii T; Murakami T; Nishijima K; Akagi T; Uji A; Arakawa N; Muraoka Y; Yoshimura N
Ophthalmology; 2012 May; 119(5):1047-55. PubMed ID: 22330965
[TBL] [Abstract][Full Text] [Related]
14. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
15. Vitreous levels of vascular endothelial growth factor and intercellular adhesion molecule 1 are related to diabetic macular edema.
Funatsu H; Yamashita H; Sakata K; Noma H; Mimura T; Suzuki M; Eguchi S; Hori S
Ophthalmology; 2005 May; 112(5):806-16. PubMed ID: 15878060
[TBL] [Abstract][Full Text] [Related]
16. Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography.
Bandyopadhyay S; Bandyopadhyay SK; Saha M; Sinha A
Int Ophthalmol; 2018 Feb; 38(1):241-249. PubMed ID: 28160192
[TBL] [Abstract][Full Text] [Related]
17. Concentration of acute phase factors in vitreous fluid in diabetic macular edema.
Kimura K; Orita T; Kobayashi Y; Matsuyama S; Fujimoto K; Yamauchi K
Jpn J Ophthalmol; 2017 Nov; 61(6):479-483. PubMed ID: 28755024
[TBL] [Abstract][Full Text] [Related]
18. Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients.
Kim JT; Lee DH; Joe SG; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 May; 54(5):3378-84. PubMed ID: 23611988
[TBL] [Abstract][Full Text] [Related]
19. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up.
Arevalo JF; Fromow-Guerra J; Quiroz-Mercado H; Sanchez JG; Wu L; Maia M; Berrocal MH; Solis-Vivanco A; Farah ME;
Ophthalmology; 2007 Apr; 114(4):743-50. PubMed ID: 17398322
[TBL] [Abstract][Full Text] [Related]
20. Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.
Roh MI; Kim HS; Song JH; Lim JB; Kwon OW
Ophthalmology; 2009 Jan; 116(1):80-6. PubMed ID: 19118699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
